Sweden· SE-20021018000022
Relestat 0,5 mg/ml Ögondroppar, lösning
A medicinal product containing epinastine hydrochloride, registered in Sweden by AbbVie AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Epinastine Hydrochloride
- Manufacturer
- AbbVie AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20021018000022
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epinastine hydrochloride in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRelestat 0.5 mg/mlAbbvie
- CzechiaPURIVISTAbbVie s.r.o., Praha
- FinlandRelestatAllergan Pharmaceuticals Ireland
- FrancePURIVIST 0,5 mg/ml, collyre en solutionABBVIE
- IrelandRelestat, 0.5 mg/ml, eye drops, solutionAbbVie Limited
- NetherlandsRelestat, oogdruppels, oplossing 0,5 mg/mlAbbVie B.V.
- PolandRelestatAbbVie Sp. z o.o.
- United StatesEPINASTINE HYDROCHLORIDESomerset Therapeutics, LLC
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Relestat
- Czechia · Purivist
- France · Purivist
- United Kingdom (Northern Ireland) · Relestat
- Greece · Optallerg, Relestat
- Hungary · Relestat
- Ireland · Relestat
- Italy · Relestat
- Luxembourg · Relestat
- Netherlands · Relestat
- Portugal · Relestat
- Slovakia · Purivist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4c2948bf-0654-4789-86d9-af364578426a GET /v1/drugs/4c2948bf-0654-4789-86d9-af364578426a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20021018000022",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20021018000022",
"product_doc_link": "https://docetp.mpa.se/LMF/Relestat%20eye%20drops%2C%20solution%20Marknadsf%C3%B6rs%20ej%20f%C3%B6r%20n%C3%A4rvarande%20SmPC_09001bee8498d167.pdf"
}See everything about epinastine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.